An open-label randomized clinical trial of novel therapeutic strategies for HIV-infected patients in whom antiretroviral therapy has failed: rationale and design of the OPTIMA Trial

By Kyriakides T.C.   Babiker A.   Singer J.   Cameron W.   Schechter M.T.   Holodniy M.   Brown S.T.   Youle M.   Gazzard B.   on behalf of the OPTIMA Study Team see Appendix  

Controlled Clinical Trials, Vol. 24, Iss. 4, 2003-08 ,pp. : 481-500

Elsevier

Access to resources Recommend Favorite

Antiretroviral Drug Guidelines for the Treatment of HIV Infection: Should Protease Inhibitors Always be Included in the Initial Regimen or Not?

By Churchill D.   Weber J.  

BioDrugs, Vol. 11, Iss. 3, 1999-03 ,pp. : 147-153

Adis International

Access to resources Recommend Favorite

Treatment of chronic lymphocytic leukemia with bendamustine in an HIV‐infected patient on antiretroviral therapy: a case report and review of the literature

By  

Clinical Case Reports, Vol. 3, Iss. 6, 2015-06 ,pp. : 453-460

John Wiley & Sons Inc

Access to resources Recommend Favorite

Diagnosing active and latent tuberculosis among Iranian HIV‐infected patients

By  

THE CLINICAL RESPIRATORY JOURNAL, Vol. 12, Iss. 1, 2018-01 ,pp. : 62-67

John Wiley & Sons Inc

Access to resources Recommend Favorite

The effect of antithrombin III substitution therapy on components of the plasma protease systems in surgical patients

By SMITH-ERICHSEN N   AASEN A O   KONGSGAARD U E   BAKKA A   BERGAN A   BJERKELUND C E   FLATMARK A   MOEN H   RAEDER M   ROSSELAND A   RØISE O   SIVERTSEN S   SKULBERG A   SOLHEIM K   STADAAS J O   SUNDE S   VAAGENES P  

Clinical Intensive Care, Vol. 7, Iss. 6, 1996-12 ,pp. : 291-291

Ashgate Publishing Ltd

Access to resources Recommend Favorite